Foekens JA - Search Results

1

The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer.

Nooter K, Brutel de la Riviere G, Look MP, van Wingerden KE, Henzen-Logmans SC, Scheper RJ, Flens MJ, Klijn JG, Stoter G, Foekens JA. Nooter K, et al. Among authors: foekens ja. Br J Cancer. 1997;76(4):486-93. doi: 10.1038/bjc.1997.414. Br J Cancer. 1997. PMID: 9275026 Free PMC article.

2

The prognostic value of polymorphonuclear leukocyte elastase in patients with primary breast cancer.

Foekens JA, Ries C, Look MP, Gippner-Steppert C, Klijn JG, Jochum M. Foekens JA, et al. Cancer Res. 2003 Jan 15;63(2):337-41. Cancer Res. 2003. PMID: 12543785

3

RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.

Burger H, Foekens JA, Look MP, Meijer-van Gelder ME, Klijn JG, Wiemer EA, Stoter G, Nooter K. Burger H, et al. Among authors: foekens ja. Clin Cancer Res. 2003 Feb;9(2):827-36. Clin Cancer Res. 2003. PMID: 12576456

4

Cell biological factors associated with the response of breast cancer to systemic treatment.

Klijn JG, Berns EM, Bontenbal M, Foekens J. Klijn JG, et al. Cancer Treat Rev. 1993 Apr;19 Suppl B:45-63. doi: 10.1016/0305-7372(93)90007-e. Cancer Treat Rev. 1993. PMID: 8481934 Review.

5

The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients.

Klijn JG, Berns PM, Schmitz PI, Foekens JA. Klijn JG, et al. Among authors: foekens ja. Endocr Rev. 1992 Feb;13(1):3-17. doi: 10.1210/edrv-13-1-3. Endocr Rev. 1992. PMID: 1313356 Free article. Review.

6

Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients.

Foekens JA, Schmitt M, van Putten WL, Peters HA, Bontenbal M, Jänicke F, Klijn JG. Foekens JA, et al. Cancer Res. 1992 Nov 1;52(21):6101-5. Cancer Res. 1992. PMID: 1394237

7

Epidermal growth factor receptor in ovarian tumours: correlation of immunohistochemistry with ligand binding assay.

Henzen-Logmans SC, Berns EM, Klijn JG, van der Burg ME, Foekens JA. Henzen-Logmans SC, et al. Among authors: foekens ja. Br J Cancer. 1992 Dec;66(6):1015-21. doi: 10.1038/bjc.1992.403. Br J Cancer. 1992. PMID: 1457340 Free PMC article.

8

Stromal influences on breast cancer cell growth.

van Roozendaal CE, van Ooijen B, Klijn JG, Claassen C, Eggermont AM, Henzen-Logmans SC, Foekens JA. van Roozendaal CE, et al. Among authors: foekens ja. Br J Cancer. 1992 Jan;65(1):77-81. doi: 10.1038/bjc.1992.14. Br J Cancer. 1992. PMID: 1733444 Free PMC article.

9

c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer.

Berns EM, Klijn JG, van Putten WL, van Staveren IL, Portengen H, Foekens JA. Berns EM, et al. Among authors: foekens ja. Cancer Res. 1992 Mar 1;52(5):1107-13. Cancer Res. 1992. PMID: 1737370

10

Prediction of relapse and survival in breast cancer patients by pS2 protein status.

Foekens JA, Rio MC, Seguin P, van Putten WL, Fauque J, Nap M, Klijn JG, Chambon P. Foekens JA, et al. Cancer Res. 1990 Jul 1;50(13):3832-7. Cancer Res. 1990. PMID: 2354435

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

411 results

Search Page